The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2 › Research Explorer

Novosibirsk State University's Research Portal

The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2

Research output: Contribution to journal › Article › peer-review

Department of Natural Sciences

DOI

https://doi.org/10.3390/antib14010023
Final published version

Vazirbek S. Aripov
Anna V. Zaykovskaya
Ludmila V. Mechetina
Alexander M. Najakshin
Alexander A. Bondar
Sergey G. Arkhipov
Egor A. Mustaev
Margarita G. Ilyina
Sophia S. Borisevich
Alexander A. Ilyichev
Valentina S. Nesmeyanova
Anastasia A. Isaeva
Ekaterina A. Volosnikova
Dmitry N. Shcherbakov
Natalia V. Volkova

Original language	English
Article number	23
Journal	Antibodies
Volume	14
Issue number	1
DOIs	https://doi.org/10.3390/antib14010023
Publication status	Published - 7 Mar 2025

OECD FOS+WOS

Research areas

AlphaFold, SARS-CoV-2, VHH, affinity selection, biopanning, molecular dynamics, nanobodies, phage library, protein–protein docking, recombinant antibodies, single-domain antibodies

ID: 65140166